A pharmaceutical composition containing several different bacteria
including Streptococcus thermophilus, Lactobacilli and Bifidobacteria is
disclosed. The bacteria are present in the composition at a total
concentration of 1.times.10.sup.11 to 1.times.10.sup.13 per gram.
Further, methods of using the pharmaceutical are disclosed which include
treatment of a gastrointestinal disorder and hypercholestermia. Also a
method for modulating a host's immune response is disclosed.